• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Edwards Lifesciences Shares Are Trading Lower By Around 17%? Here Are 47 Stocks Moving In Friday's Mid-Day Session

    10/28/22 12:12:36 PM ET
    $AGFY
    $AGLE
    $AHPA
    $AMZN
    Farming/Seeds/Milling
    Consumer Staples
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AGFY alert in real time by email

    Gainers

    • Quanergy Systems, Inc. (NASDAQ:QNGY) surged 179% to $3.6301.
    • Nuvalent, Inc. (NASDAQ:NUVL) shares jumped 62% to $35.60 after the company reported preliminary Phase 1 clinical data from the ARROS-1 trial that support the best-in-class potential of NVL-520 for patients with ROS1-positive NSCLC.
    • Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE) climbed 38% to $0.7860 after jumping 15% on Thursday.
    • Sierra Metals Inc. (NYSE:SMTS) gained 32% to $0.2201. Sierra Metals' largest shareholder and Compañia Minera Kolpa announced Letter of Intent for Sierra Metals transaction and financing.
    • Rail Vision Ltd. (NASDAQ:RVSN) jumped 31.6% to $0.7899.
    • Agrify Corporation (NASDAQ:AGFY) surged 31% to $2.1657. Agrify issued an update on its at-the-market equity program.
    • Data I/O Corporation (NASDAQ:DAIO) gained 25% to $3.8485 after the company reported better-than-expected Q3 results.
    • Provident Acquisition Corp. (NASDAQ:PAQC) shares gained 22.4% to $10.15. Perfect Corp. and Provident Acquisition Corp. recently announced approval of business combination by Provident's shareholders.
    • Starry Group Holdings, Inc. (NYSE:STRY) gained 20% to $0.34.
    • TAL Education Group (NYSE:TAL) climbed 16.3% to $4.6180 after the company reported better-than-expected Q2 results.
    • Bull Horn Holdings Corp. (NASDAQ:BHSE) surged 15.5% to $9.54.
    • Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO) rose 15.3% to $3.4250.
    • 8x8, Inc. (NYSE:EGHT) surged 15% to $3.9189 after the company announced better-than-expected Q2 EPS and sales results.
    • Biotricity, Inc. (NASDAQ:BTCY) gained 14.5% to $1.42.
    • Grand Canyon Education, Inc. (NASDAQ:LOPE) rose 14.5% to $99.97 following strong Q3 results.
    • TESSCO Technologies Incorporated (NASDAQ:TESS) surged 14.5% to $4.98 after the company reported better-than-expected Q2 results.
    • Pinterest, Inc. (NYSE:PINS) rose 10.4% to $24.16 after the company reported better-than-expected Q3 results.
    • Gilead Sciences, Inc. (NASDAQ:GILD) rose 9.7% to $76.99 after the company reported better-than-expected Q3 results.
    • Intel Corporation (NASDAQ:INTC) rose 8.5% to $28.50 after the company posted better-than-expected earnings for its third quarter. The company also issued weak guidance for FY22. Intel is focused on cost reductions going forward with a plan for $3 billion in savings in 2023 and cost savings of $8 billion to $10 billion annually by 2025.
    • Core Scientific, Inc. (NASDAQ:CORZ) rose 7.6% to $0.2376. Core Scientific shares dipped 78% on Thursday after the company said, given the uncertainty regarding its financial condition, substantial doubt exists about the company's ability to continue as a going concern for a reasonable period of time.


    Losers

    • Greenlane Holdings, Inc. (NASDAQ:GNLN) fell 63.1% to $ 0.45 after the company reported a $7.5 million public offering.
    • Selina Hospitality PLC (NASDAQ:SLNA) shares dipped 44.7% to $22.31.
    • Verb Technology Company, Inc. (NASDAQ:VERB) fell 33% to $0.1950. Verb Technology recently announced a $4 million registered direct offering.
    • DaVita Inc. (NYSE:DVA) fell 24.9% to $72.68 after the company reported worse-than-expected Q3 EPS and sales results and lowered FY22 adjusted EPS guidance below estimates.
    • Avista Public Acquisition Corp. II (NASDAQ:AHPA) fell 18.4% to $7.00.
    • Cazoo Group Ltd (NYSE:CZOO) dropped 17% to $0.2999. Cazoo, on Thursday, reported Q3 sales of £347 million.
    • Edwards Lifesciences Corporation (NYSE:EW) fell 16.8% to $71.78 after the company reported worse-than-expected Q3 results. The company also lowered its FY22 EPS guidance below analyst estimates.
    • LeMaitre Vascular, Inc. (NASDAQ:LMAT) dropped 16.7% to $43.19 after the company reported worse-than-expected Q3 EPS and sales results. The company also issued Q4 EPS and FY22 EPS and sales guidance below analyst estimates.
    • United Fire Group, Inc. (NASDAQ:UFCS) dropped 15.8% to $26.73 after Piper Sandler downgraded the stock from Overweight to Neutral and lowered its price target from $37 to $31.
    • Carlisle Companies Incorporated (NYSE:CSL) declined 15.5% to $238.91 after the company reported Q3 earnings results.
    • FedNat Holding Company (NASDAQ:FNHC) fell 15.5% to $0.3081 after dropping 13% on Thursday. The company announced voluntary Nasdaq delisting.
    • Heart Test Laboratories, Inc. (NASDAQ:HSCS) dipped 15.4% to $2.2257.
    • GDS Holdings Limited (NASDAQ:GDS) fell 14.7% to $9.50.
    • Nexa Resources S.A. (NYSE:NEXA) declined 14.3% to $5.02 after the company reported Q3 EPS results down from last year.
    • World Fuel Services Corporation (NYSE:INT) dipped 14% to $23.39 after the company reported worse-than-expected Q3 sales results.
    • PTC Therapeutics, Inc. (NASDAQ:PTCT) fell 12.9% to $38.84. PTC Therapeutics entered into a strategic financing collaboration with Blackstone.
    • Betterware de México, S.A.P.I. de C.V. (NASDAQ:BWMX) dropped 12% to $7.31 after the company reported Q3 financial results.
    • Eldorado Gold Corporation (NYSE:EGO) fell 11.4% to $5.44 after the company reported worse-than-expected Q3 EPS and sales results.
    • Better Choice Company Inc. (NYSE:BTTR) dropped 11.2% to $0.9499.
    • XPeng Inc. (NYSE:XPEV) fell 9.4% to $6.66 after dropping 10% on Thursday. Citigroup downgraded XPeng from Buy to Sell and announced a $3.18 price target. Cities in China ranging from Wuhan in central China to Xining in the north-west are doubling down on COVID-19 curbs, reported Reuters.
    • NuZee, Inc. (NASDAQ:NUZE) shares fell 9.2% to $0.3451 after jumping 15% on Thursday.
    • Zai Lab Limited (NASDAQ:ZLAB) fell 9.2% to $23.35. Zai Lab is expected to announce Q3 financial results on November 9, 2022.
    • Bed Bath & Beyond Inc. (NASDAQ:BBBY) dipped 8.7% to $4.5450 after the company announced a common stock offering of up to $150 million.
    • Amazon.com, Inc. (NASDAQ:AMZN) shares fell 8.6% to $101.44. Amazon.com reported upbeat earnings for its third quarter, while sales missed estimates. The company also issued weak sales forecast for the fourth quarter.
    • Freight Technologies, Inc. (NASDAQ:FRGT) fell 7.7% to $0.5901. Freight Technologies recently entered into new Fr8Private Fleet multi-year commitment with Kimberly Clark De Mexico, S.A.B. de C.V.
    • NatWest Group plc (NYSE:NWG) shares fell 8.7% to $ 5.22 after the company posted downbeat Q3 profit.
    • Li Auto Inc. (NASDAQ:LI) fell 7% to $13.94 after declining 8% on Thursday. Barclays maintained Li Auto with an Overweight and lowered the price target from $40 to $25. Cities in China ranging from Wuhan in central China to Xining in the north-west are doubling down on COVID-19 curbs, reported Reuters.
    Get the next $AGFY alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AGFY
    $AGLE
    $AHPA
    $AMZN

    CompanyDatePrice TargetRatingAnalyst
    Edwards Lifesciences Corporation
    $EW
    4/1/2026$92.00Peer Perform → Outperform
    Wolfe Research
    Nuvalent Inc.
    $NUVL
    3/30/2026$116.00Overweight
    Wells Fargo
    Amazon.com Inc.
    $AMZN
    3/25/2026$265.00 → $280.00Overweight
    Analyst
    XPeng Inc.
    $XPEV
    3/23/2026$19.00Outperform → Neutral
    Macquarie
    Li Auto Inc.
    $LI
    3/17/2026$19.00Buy → Neutral
    Goldman
    Gilead Sciences Inc.
    $GILD
    3/10/2026$180.00Buy
    Jefferies
    Core Scientific Inc.
    $CORZ
    3/3/2026$23.00Hold → Buy
    Needham
    Pinterest Inc.
    $PINS
    3/2/2026Buy → Hold
    Argus
    More analyst ratings

    $AGFY
    $AGLE
    $AHPA
    $AMZN
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    March 11, 2025 - FDA Roundup: March 11, 2025

    For Immediate Release: March 11, 2025 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:Today, the FDA published a General Correspondence Letter issued to Mid-Link Technology Testing Co., Ltd. The FDA is vigilant in ensuring data submitted to the FDA can be relied upon to assess the effectiveness, safety, or risk of a device. The FDA has noted an incr

    3/13/25 3:14:00 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    FDA Approval for SUNLENCA issued to GILEAD SCIENCES INC

    Submission status for GILEAD SCIENCES INC's drug SUNLENCA (SUPPL-6) with active ingredient LENACAPAVIR SODIUM has changed to 'Approval' on 11/25/2024. Application Category: NDA, Application Number: 215973, Application Classification: Efficacy

    11/26/24 4:36:21 AM ET
    $GILD
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    FDA Approval for SUNLENCA issued to GILEAD SCIENCES INC

    Submission status for GILEAD SCIENCES INC's drug SUNLENCA (SUPPL-8) with active ingredient LENACAPAVIR SODIUM has changed to 'Approval' on 11/25/2024. Application Category: NDA, Application Number: 215974, Application Classification: Efficacy

    11/26/24 4:36:21 AM ET
    $GILD
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AGFY
    $AGLE
    $AHPA
    $AMZN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Tabacco Joseph J Jr bought $102,200 worth of shares (20,000 units at $5.11) (SEC Form 4)

    4 - BED BATH & BEYOND, INC. (0001130713) (Issuer)

    3/12/26 8:32:43 PM ET
    $BBBY
    Catalog/Specialty Distribution
    Consumer Discretionary

    Director Weiss Eric Stanton bought $101,700 worth of shares (7,000 units at $14.53), increasing direct ownership by 3% to 252,262 units (SEC Form 4)

    4 - Core Scientific, Inc./tx (0001839341) (Issuer)

    3/10/26 4:08:53 PM ET
    $CORZ
    Finance: Consumer Services
    Finance

    EVP, CFO Zinsner David bought $249,985 worth of shares (5,882 units at $42.50), increasing direct ownership by 2% to 247,392 units (SEC Form 4)

    4 - INTEL CORP (0000050863) (Issuer)

    1/27/26 4:28:29 PM ET
    $INTC
    Semiconductors
    Technology

    $AGFY
    $AGLE
    $AHPA
    $AMZN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Intel Appoints Aparna Bawa as Executive Vice President and Chief Legal & People Officer

    Intel Corporation today announced the appointment of Aparna Bawa as EVP, chief legal & people officer. Bawa will report directly to CEO Lip-Bu Tan and will lead Intel's global legal, ethics, compliance, people, and culture organizations as the company accelerates its transformation and execution agenda. "The role of legal and people leadership has never been more critical as Intel drives cultural transformation with discipline, speed, and integrity," said Intel CEO Lip-Bu Tan. "Aparna brings a rare combination of operational rigor, business judgment, and people-first leadership. Her experience helping scale global technology companies through periods of significant change will be invaluab

    4/2/26 4:05:00 PM ET
    $INTC
    Semiconductors
    Technology

    Bed Bath & Beyond, Inc. to Expand Elfa International as a Global Growth Platform Under Existing Leadership

    Bed Bath & Beyond, Inc. (NYSE:BBBY) ("Bed Bath & Beyond" or "BBBY") today announced plans to significantly expand Elfa as a core growth platform within its Home Services Pillar, alongside the signing of definitive agreements that include The Container Store and Closet Works. Founded in Stockholm, Sweden in 1948, Elfa is one of the world's leading modular storage and organization brands, known for its customizable closet systems, shelving solutions, and space optimization products. The brand has built a reputation for durability, flexibility, and design, and has historically been distributed in the United States primarily through The Container Store. As part of this next phase, Anders Ro

    4/2/26 1:09:00 PM ET
    $BBBY
    Catalog/Specialty Distribution
    Consumer Discretionary

    Letter to Shareholders from Marcus Lemonis, Executive Chairman and CEO: The Growth Phase

    Bed Bath & Beyond, Inc. (NYSE:BBBY) ("Bed Bath & Beyond" or "BBBY") has issued the following letter from Marcus Lemonis, Executive Chairman and Chief Executive Officer of Bed Bath & Beyond: Dear Shareholders, I want to start by sharing how I think about the acquisition of The Container Store, Elfa, and Closet Works, and why I believe this transaction is a critical step for our company. For the past eighteen months, we have studied this business closely. In 2024, we had the opportunity to invest and chose not to move forward due to my concerns around leadership, strategic direction of the brand, and the health of the company's balance sheet. Shortly thereafter, the business entered ban

    4/2/26 8:02:00 AM ET
    $BBBY
    Catalog/Specialty Distribution
    Consumer Discretionary

    $AGFY
    $AGLE
    $AHPA
    $AMZN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Edmondson Frazor Titus Iii

    4 - Zai Lab Ltd (0001704292) (Issuer)

    4/3/26 5:58:53 PM ET
    $ZLAB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Smiley Joshua L

    4 - Zai Lab Ltd (0001704292) (Issuer)

    4/3/26 5:59:18 PM ET
    $ZLAB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Amado Rafael

    4 - Zai Lab Ltd (0001704292) (Issuer)

    4/3/26 5:57:35 PM ET
    $ZLAB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGFY
    $AGLE
    $AHPA
    $AMZN
    SEC Filings

    View All

    HeartSciences Inc. filed SEC Form 8-K: Leadership Update

    8-K - HeartSciences Inc. (0001468492) (Filer)

    4/3/26 5:15:10 PM ET
    $HSCS
    Industrial Specialties
    Health Care

    Intel Corporation filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - INTEL CORP (0000050863) (Filer)

    4/3/26 12:50:37 PM ET
    $INTC
    Semiconductors
    Technology

    SEC Form 144 filed by Zai Lab Limited

    144 - Zai Lab Ltd (0001704292) (Subject)

    4/2/26 4:59:22 PM ET
    $ZLAB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGFY
    $AGLE
    $AHPA
    $AMZN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Edwards Lifesciences upgraded by Wolfe Research with a new price target

    Wolfe Research upgraded Edwards Lifesciences from Peer Perform to Outperform and set a new price target of $92.00

    4/1/26 8:10:23 AM ET
    $EW
    Industrial Specialties
    Health Care

    Wells Fargo initiated coverage on Nuvalent with a new price target

    Wells Fargo initiated coverage of Nuvalent with a rating of Overweight and set a new price target of $116.00

    3/30/26 8:25:33 AM ET
    $NUVL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Analyst reiterated coverage on Amazon with a new price target

    Analyst reiterated coverage of Amazon with a rating of Overweight and set a new price target of $280.00 from $265.00 previously

    3/25/26 10:59:48 AM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    $AGFY
    $AGLE
    $AHPA
    $AMZN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Pinterest Inc.

    SC 13G/A - PINTEREST, INC. (0001506293) (Subject)

    12/6/24 10:11:26 AM ET
    $PINS
    Computer Software: Programming Data Processing
    Technology

    Amendment: SEC Form SC 13D/A filed by Agrify Corporation

    SC 13D/A - Agrify Corp (0001800637) (Subject)

    11/29/24 4:30:03 PM ET
    $AGFY
    Farming/Seeds/Milling
    Consumer Staples

    Amendment: SEC Form SC 13D/A filed by Agrify Corporation

    SC 13D/A - Agrify Corp (0001800637) (Subject)

    11/29/24 4:30:03 PM ET
    $AGFY
    Farming/Seeds/Milling
    Consumer Staples

    $AGFY
    $AGLE
    $AHPA
    $AMZN
    Leadership Updates

    Live Leadership Updates

    View All

    Intel Appoints Aparna Bawa as Executive Vice President and Chief Legal & People Officer

    Intel Corporation today announced the appointment of Aparna Bawa as EVP, chief legal & people officer. Bawa will report directly to CEO Lip-Bu Tan and will lead Intel's global legal, ethics, compliance, people, and culture organizations as the company accelerates its transformation and execution agenda. "The role of legal and people leadership has never been more critical as Intel drives cultural transformation with discipline, speed, and integrity," said Intel CEO Lip-Bu Tan. "Aparna brings a rare combination of operational rigor, business judgment, and people-first leadership. Her experience helping scale global technology companies through periods of significant change will be invaluab

    4/2/26 4:05:00 PM ET
    $INTC
    Semiconductors
    Technology

    Greenlane Reports Fourth Quarter and Full Year 2025 Financial Results

    BOCA RATON, Fla., March 31, 2026 (GLOBE NEWSWIRE) -- Greenlane Holdings, Inc. ("Greenlane" or the "Company") (NASDAQ:GNLN), a publicly traded digital asset treasury company focused on the acquisition, management, and strategic deployment of BERA, the native token of the Berachain blockchain network, today reported its financial results for the fourth quarter and full year ended December 31, 2025. Digital Asset Treasury Strategy In October 2025, following the closing of a private placement that raised $110.7M in capital, Greenlane adopted a Treasury Policy and initiated a strategic shift toward a digital asset treasury strategy focused on BERA, the native token of the Berachain blockchain

    3/31/26 5:01:24 PM ET
    $GNLN
    Durable Goods
    Consumer Discretionary

    PTC Therapeutics Appoints Biotech Banking Pioneer Jessica Chutter to Board of Directors

    WARREN, N.J., March 25, 2026 /PRNewswire/ -- PTC Therapeutics, Inc., (NASDAQ:PTCT) today announced the appointment of Jessica Chutter to its Board of Directors. Ms. Chutter is a highly accomplished biotechnology investment banker with an extensive list of achievements over her long tenure at Morgan Stanley, including building and leading the bank's biotechnology franchise.  "I have closely followed Jessica's illustrious career, and I am proud to welcome her to PTC's Board of Directors," said Michael Schmertzler, Chairman of the Board of Directors. "Jessica will play an integral role as the Board continues to work with the management team on charting the company's next stage of growth."Ms. Ch

    3/25/26 8:30:00 AM ET
    $PTCT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGFY
    $AGLE
    $AHPA
    $AMZN
    Financials

    Live finance-specific insights

    View All

    Grand Canyon Education, Inc. Announces First Quarter 2026 Earnings Release Date and Conference Call Details

    PHOENIX, April 1, 2026 /PRNewswire/ -- Grand Canyon Education, Inc. (Nasdaq: LOPE) announced today that it will report its 2026 first quarter results and full year outlook for 2026 after market close on Thursday, April 30, 2026. The Company will host a conference call to discuss the results in more detail at 1:30 P.M. (4:30 P.M. ET) the same day. Live Conference Dial-In:Those interested in participating in the question-and-answer session should follow the conference dial-in instructions below.Participants may register for the call here to receive the dial-in numbers and unique P

    4/1/26 4:15:00 PM ET
    $LOPE
    Other Consumer Services
    Real Estate

    Eldorado Gold Reminds Shareholders to Vote FOR the Share Issuance Resolution and Foran Mining Reminds Securityholders to Vote FOR the Arrangement Resolution

    Your vote is important. Vote in advance of the proxy voting deadline on Thursday, April 2, 2026 at 10:00 a.m. (Vancouver time).Shareholder questions or need voting assistance? Please contact Laurel Hill Advisory Group by email at [email protected], or by texting INFO to, or calling, 1-877-452-7184 (North American toll-free) or 1-416-304-0211 (outside North America). VANCOUVER, British Columbia, April 01, 2026 (GLOBE NEWSWIRE) -- Eldorado Gold Corporation (TSX:ELD) (NYSE:EGO) ("Eldorado") reminds its shareholders to vote FOR the ordinary resolution approving the issuance of common shares of Eldorado (the "Share Issuance Resolution") in connection with the previously announced propo

    4/1/26 7:00:00 AM ET
    $EGO
    Precious Metals
    Basic Materials

    Intel to Report First-Quarter 2026 Financial Results

    Intel Corporation today announced that it will report first-quarter financial results on Thursday, April 23, 2026, promptly after close of market. Intel will then hold an earnings conference call at 2 p.m. PT that day to discuss the results. A live public webcast of the earnings conference call can be accessed on Intel's Investor Relations website at intc.com. Associated materials and webcast replay will also be available on the site. About Intel Intel (NASDAQ:INTC) designs and manufactures advanced semiconductors that connect and power the modern world. Every day, our engineers create new technologies that enhance and shape the future of computing to enable new possibilities for ever

    3/31/26 5:02:00 PM ET
    $INTC
    Semiconductors
    Technology